|
Market Closed -
Nasdaq
16:00:00 2026-09-24 EDT
|
5-day change | 1st Jan Change | ||
| 8.520 USD | -0.58% |
|
-2.07% | +9.23% |
| Market Cap | 2.17B 1.91B 1.8B 1.65B 3.08B 209B 3.1B 21.64B 8.39B 106B 8.16B 7.99B 346B | P/E 2026 * |
-3.71x | P/E 2027 * | 12.8x |
|---|---|---|---|---|---|
| Enterprise Value | 2.17B 1.91B 1.8B 1.65B 3.08B 209B 3.1B 21.64B 8.39B 106B 8.16B 7.99B 346B | EV / Sales 2026 * |
3.1x | EV / Sales 2027 * | 2.95x |
| Free-Float |
94.69% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BCRX | Delayed | |
CBOE
| BCRX | Real-time | |
|
Boerse Muenchen
| BO1 | Real-time | |
|
Mexican S.E.
| BCRX * | End-of-day quote | |
|
Tradegate
| BO1 | Real-time | |
|
Deutsche Boerse AG
| BO1 | Delayed | |
|
Börse Stuttgart
| BO1 | Delayed | |
|
Berne S.E.
| BO1 | End-of-day quote |
Last Transcript: BioCryst Pharmaceuticals, Inc.
| 1 day | -0.58% | ||
| 1 week | -2.07% | ||
| Current month | -12.16% | ||
| 1 month | -11.98% | ||
| 3 months | -14.80% | ||
| 6 months | -11.80% | ||
| Current year | +9.23% |
| 1 week | 8.4 |  | 9.04 |
| 1 month | 8.02 | | 10.23 |
| Current year | 6.23 | | 11.22 |
| 1 year | 6 | | 11.22 |
| 3 years | 4.03 | | 11.31 |
| 5 years | 4.03 | | 19.99 |
| 10 years | 1.38 | | 19.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charles Gayer
CEO | Chief Executive Officer | 55 | 2025-12-31 |
Babar Ghias
DFI | Director of Finance/CFO | 47 | 2025-07-06 |
Sandeep Menon
CTO | Chief Tech/Sci/R&D Officer | 51 | 2026-04-05 |
| Director | Title | Age | Since |
|---|---|---|---|
Jon Stonehouse
BRD | Director/Board Member | 65 | 2006-12-31 |
Theresa Heggie
BRD | Director/Board Member | 64 | 2018-12-02 |
Charles Gayer
BRD | Director/Board Member | 55 | 2025-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/31/26 | Free | Director | 644 | 0.0003% | ||
| 8/31/26 | Free | Director | 644 | 0.0003% | ||
| 8/31/26 | Free | Director | 1,288 | 0.0005% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.58% | -2.07% | +9.65% | +15.92% | 2.19B | |
| -3.30% | +1.19% | +54.62% | +104.15% | 74.18B | |
| -0.12% | -3.82% | +34.21% | +74.86% | 59.55B | |
| +2.71% | -1.96% | -13.79% | +364.46% | 25.84B | |
| +0.81% | +0.61% | -0.49% | -5.14% | 24.73B | |
| -1.05% | +1.07% | +21.45% | -10.32% | 20.87B | |
| -1.70% | -3.35% | +146.86% | +325.69% | 15.32B | |
| +2.15% | -0.92% | +48.93% | +169.79% | 14.06B | |
| -0.43% | -7.56% | -20.10% | +775.94% | 13.12B | |
| +0.04% | -3.97% | +20.23% | +234.69% | 11.85B | |
| Average | -0.15% | -1.45% | +30.16% | +205.00% | 26.17B | |
| Weighted average by Cap. | -0.71% | -0.84% | +34.78% | +159.09% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 702M 618M 582M 531M 994M 67.41B 1B 6.99B 2.71B 34.31B 2.64B 2.58B 112B | 737M 649M 611M 558M 1.04B 70.77B 1.05B 7.34B 2.84B 36.02B 2.77B 2.71B 117B |
| Net income | -579M -509M -480M -438M -819M -55.56B -825M -5.76B -2.23B -28.28B -2.17B -2.13B -92.01B | 184M 162M 153M 140M 261M 17.71B 263M 1.84B 711M 9.01B 693M 677M 29.32B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-24 | US$8.520 | -0.58% | 4,852,998 |
| 26-09-23 | US$8.570 | -2.39% | 4,466,765 |
| 26-09-22 | US$8.780 | +0.23% | 3,442,408 |
| 26-09-21 | US$8.760 | +0.92% | 3,462,946 |
| 26-09-18 | US$8.680 | -0.23% | 12,746,888 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BCRX Stock
Select your edition
All financial news and data tailored to specific country editions
